LCLIX
Price
$38.37
Change
-$1.36 (-3.42%)
Updated
Apr 3 closing price
Net Assets
2.34B
RMEBX
Price
$54.45
Change
-$1.82 (-3.23%)
Updated
Apr 3 closing price
Net Assets
102.75B
Ad is loading...

LCLIX vs RMEBX

Header iconLCLIX vs RMEBX Comparison
Open Charts LCLIX vs RMEBXBanner chart's image
ClearBridge Large Cap Value 1
Price$38.37
Change-$1.36 (-3.42%)
VolumeN/A
Net Assets2.34B
American Funds American Mutual R2E
Price$54.45
Change-$1.82 (-3.23%)
VolumeN/A
Net Assets102.75B
LCLIX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LCLIX vs. RMEBX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCLIX is a Buy and RMEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 103B vs. LCLIX (2.34B). LCLIX pays higher dividends than RMEBX: LCLIX (1.37) vs RMEBX (1.18). LCLIX was incepted earlier than RMEBX: LCLIX (12 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than LCLIX (0.61). RMEBX is a more actively managed with annual turnover of: 31.00 vs. LCLIX (22.00). LCLIX has a lower initial minimum investment than RMEBX: LCLIX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 6.63 vs. LCLIX (-5.96). RMEBX return over 5 years is better than : 74.87 vs. LCLIX (70.85).
LCLIXRMEBXLCLIX / RMEBX
Total Expense Ratio0.611.0757%
Annual Report Gross Expense Ratio0.611.0757%
Fund Existence12 years11 years-
Gain YTD0.9482.77434%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.34B103B2%
Annual Yield % from dividends1.371.18116%
Returns for 1 year-5.966.63-90%
Returns for 3 years6.1211.0056%
Returns for 5 years70.8574.8795%
Returns for 10 years52.9763.2284%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITGIX90.00N/A
N/A
VY® T. Rowe Price Growth Equity I
VCAAX11.31N/A
N/A
VALIC Company I Asset Allocation
WSTAX46.97N/A
N/A
Macquarie Science and Technology A
MPLIX13.50N/A
N/A
Praxis International Index I
PDFDX41.89-2.13
-4.84%
Perkins Discovery